Ikarian Capital LLC 13D and 13G filings for Odonate Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:36 pm Sale | 2021-12-31 | 13G | Odonate Therapeutics, Inc. ODTC | Ikarian Capital LLC | 0 3.500% | -0 (-32.51%) | Filing |
| 2021-07-02 4:05 pm Purchase | 2021-06-11 | 13G | Odonate Therapeutics, Inc. ODTC | Ikarian Capital LLC | 0 5.200% | 0 (New Position) | Filing |